Pancreatic Cancer Research

ResearcherShiga University of Medical ScienceNo recent work listed

Yonson Ku

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2856-6885; OpenAlex author ID A5078918448, A5109030737. Sources: OpenAlex.

Their work

Papers
15 (first author 0, last author 11)
Trials
0
Grants
0
Labs led
1
Collaborators
44
Papers, trials and grants by year

2011: 2 papers · 2012: 2 papers · 2013: 2 papers · 2014: 1 paper · 2015: 2 papers · 2016: 1 paper · 2017: 3 papers · 2018: 1 paper · 2019: none · 2020: 1 paper

Papers 15

  1. [A Case of Pancreatic Adenocarcinoma with Inferior Vena Cava Invasion]. Last author PMID 32389967↗
  2. Pancreatic inflammation and atrophy are not associated with pancreatic cancer concomitant with intraductal papillary mucinous neoplasm. Co-author DOI 10.1016/j.pan.2017.12.007↗
  3. Smoking Status and the Incidence of Pancreatic Cancer Concomitant With Intraductal Papillary Mucinous Neoplasm. Co-author DOI 10.1097/mpa.0000000000000761↗
  4. Pancreatic ductal adenocarcinoma with inferior vena cava invasion: a report of three resected cases. Last author DOI 10.1186/s40792-017-0348-5↗
  5. [A Case of Pancreatic Cancer with Multiple Lymph Node Swelling Caused by Sarcoidosis]. Last author PMID 29394809↗
  6. Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophi… Last author DOI 10.1007/s00595-015-1206-3↗
  7. Proposed preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after surgical resection: A multi-center r… Last author DOI 10.1016/j.pan.2015.09.008↗
  8. Postoperative Serum Albumin Level is a Marker of Incomplete Adjuvant Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1245/s10434-014-4280-7↗
  9. [A case of adjuvant surgery for a patient with initially unresectable locally advanced pancreatic cancer (LAPC) with a favorable response to S-1 chemotherapy]. Last author PMID 25731462↗
  10. 18-Fluorodeoxyglucose positron emission tomography does not aid in diagnosis of pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.cgh.2012.12.033↗
  11. [A case of metachronous pancreatic cancer that developed 4 years after initial pancreatectomy]. Last author PMID 24393957↗
  12. A phase I/II study of gemcitabine-concurrent proton radiotherapy for locally advanced pancreatic cancer without distant metastasis. Co-author DOI 10.1016/j.radonc.2011.12.029↗
  13. [A case of interstitial lung disease associated with gemcitabine treatment in a patient with locally advanced pancreatic cancer following proton beam radiother… Last author PMID 23268009↗
  14. A focal mass-forming autoimmune pancreatitis mimicking pancreatic cancer with obstruction of the main pancreatic duct. Last author DOI 10.1007/s11605-011-1543-5↗
  15. Hypoxia induces tumor aggressiveness and the expansion of CD133-positive cells in a hypoxia-inducible factor-1α-dependent manner in pancreatic cancer cells. Co-author DOI 10.1159/000325538↗

Closest collaborators

The 25 strongest of 44 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Takumi Fukumoto · 12 shared papers, 2011–2018 · strength 0.54
  2. Tadahiro Goto · 11 shared papers, 2011–2020 · strength 0.53
  3. Sadaki Asari · 10 shared papers, 2011–2017 · strength 0.42
  4. Hirochika Toyama · 7 shared papers, 2011–2018 · strength 0.31
  5. Ippei Matsumoto · 8 shared papers, 2011–2016 · strength 0.30
  6. Keitaro Sofue · 3 shared papers, 2017–2018 · strength 0.18
  7. Jun Ishida · 4 shared papers, 2013–2016 · strength 0.17
  8. Sachiyo Shirakawa · 4 shared papers, 2012–2017 · strength 0.16
  9. Motofumi Tanaka · 3 shared papers, 2014–2017 · strength 0.16
  10. Takuya Mizumoto · 2 shared papers, 2017 · strength 0.12
  11. Mamoru Takenaka · 2 shared papers, 2017–2018 · strength 0.12
  12. Atsuhiro Masuda · 2 shared papers, 2017–2018 · strength 0.12
  13. Takeshi Azuma · 2 shared papers, 2017–2018 · strength 0.12
  14. Yosuke Yagi · 2 shared papers, 2017–2018 · strength 0.12
  15. Takashi Kobayashi · 2 shared papers, 2017–2018 · strength 0.12
  16. Yoh Zen · 2 shared papers, 2017–2018 · strength 0.12
  17. Masaru Yoshida · 2 shared papers, 2017–2018 · strength 0.12
  18. Yoshihide Nanno · 2 shared papers, 2014–2017 · strength 0.09
  19. Masaki Tanaka · 2 shared papers, 2012–2015 · strength 0.07
  20. Takuya Ikegawa · 1 shared paper, 2018 · strength 0.06
  21. Takashi Nakagawa · 1 shared paper, 2018 · strength 0.06
  22. Takashi Nakagawa · 1 shared paper, 2017 · strength 0.06
  23. Mototsugu Shimokawa · 1 shared paper, 2015 · strength 0.04
  24. Yoshiaki Murakami · 1 shared paper, 2015 · strength 0.04
  25. Sohei Satoi · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.